Daily haemodialysis improves indices of protein glycation
نویسندگان
چکیده
منابع مشابه
The re-emergence of short daily haemodialysis
Thrice weekly in-center hemodialysis is the standard of care for dialysis patients with end-stage renal disease (ESRD). However, there is ongoing debate as to whether more frequent hemodialysis, with its readier management of both toxin and fluid removal, benefits patients. New evidence from recent studies, both in center dialysis and in home haemodialysis patients, adds further confirmation of...
متن کاملA crossover study of short daily haemodialysis.
BACKGROUND The benefits of daily haemodialysis (DHD) compared to conventional three times per week haemodialysis (CHD) have been described in a number of observational studies. Most of these previous studies however have not been performed with rigorous controls. METHODS We performed a crossover study following an A-B-A design: phase A was 4 weeks of thrice weekly dialysis, 3-4 h per treatmen...
متن کاملEffect of permeability on indices of haemodialysis membrane biocompatibility.
BACKGROUND Increases in plasma anaphylatoxins frequently are used as an index of haemodialysis membrane biocompatibility; however, their plasma levels may be influenced by the loss of anaphylatoxins into the dialysate compartment. METHODS We compared the generation and compartmental distribution of anaphylatoxins, C3a and C5a, in a high flux and a low flux polysulfone membrane dialyser when w...
متن کاملMeasurement of protein glycation, glycated peptides, and glycation free adducts.
Protein glycation adducts, early glycation adducts, such as N(epsilon)-fructosyl-lysine, and advanced glycation end products (AGEs) are uremic toxins. Glycation adducts are found in plasma and tissue proteins (glycation adduct residues), in peptides (glycation adduct peptide residues), and glycated amino acids (glycation free adducts). The latter two analyte groups arise from proteolysis of gly...
متن کاملCardiovascular benefits of daily haemodialysis: peeling the onion.
Patients with chronic kidney disease (CKD) suffer rates of cardiovascular (CV) morbidity and mortality that are far in excess of those found in the general population. This excess mortality is particularly striking amongst younger people [1]. The modification of so-called ‘classical’ CV risk factors has little impact on overall rates of morbidity and mortality, particularly in patients undergoi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nephrology Dialysis Transplantation
سال: 2002
ISSN: 1460-2385
DOI: 10.1093/ndt/17.5.871